Amine substituted compounds

Details Amine substituted compounds Amine substituted compounds

1995-06-07

2000-08-15

Berch, Mark L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514265, 544268, 544269, 544270, 544271, 544272, A61K 31522, C07D47310

Patent

active

061037303

ABSTRACT:
Compounds and pharmaceutical compositions, including resolved enantiomers and/or diastereomers, hydrates, salts, solvates and mixtures thereof, have the formula:

REFERENCES:
patent: 3245994 (1966-04-01), Klinger
patent: 3422104 (1969-01-01), Mohler et al.
patent: 3728346 (1973-04-01), Klinger
patent: 3737433 (1973-06-01), Mohler et al.
patent: 4061753 (1977-12-01), Bodor et al.
patent: 4144340 (1979-03-01), Offermans
patent: 4275064 (1981-06-01), Bodor et al.
patent: 4279992 (1981-07-01), Boguslaski
patent: 4299832 (1981-11-01), Brown
patent: 4374837 (1983-02-01), Favier et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4542137 (1985-09-01), Klessing
patent: 4558051 (1985-12-01), Sunshine et al.
patent: 4565817 (1986-01-01), Korbonits et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4618612 (1986-10-01), Baglioni
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4784994 (1988-11-01), Romer et al.
patent: 4833146 (1989-05-01), Gebert et al.
patent: 4845081 (1989-07-01), Sloan
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5039666 (1991-08-01), Novick, Jr.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5118500 (1992-06-01), Hanel et al.
patent: 5126340 (1992-06-01), Tseng et al.
patent: 5196439 (1993-03-01), Sugimoto et al.
patent: 5247086 (1993-09-01), Cain et al.
patent: 5272153 (1993-12-01), Mandell et al.
patent: B13737433 (1987-03-01), Mohler et al.
Ridder, Chem Abs 60, 15892a.
Habersang, Arzneim-Forsch/Drugs Res 27 (1A), p14-21(1977).
Bianco et al., Blood, 76: Supplement 1 (522), p. 133a, "Pentoxifylline (PTX) and GM-CSF Decrease Tumor Necrosis Factor-ALPHA (TNF-.alpha.) Levels in Patients Undergoing Allogeneic Bone Marrow Transplantation (BMT)", 1990.
Bianco et al., Blood, 78:5, pp. 1205-1211, "Phase I-II Trial of Pentoxifylline for the Prevention of Transplant-Related Toxicities Following Bone Marrow Transplantation", Sep. 1991.
Bursten et al., The Journal of Biological Chemistry, vol. 266, No. 31, pp. 20732-20743, "Interleukin-1 Rapidly Stimulates Lysophosphatidate Acyltransferase and Phosphatidate Phosphohydrolase activities in Human Mesangial Cells", Nov. 1991.
Davis et al., Applied Environment Microbial., 48:2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifylline", Aug. 1984.
Ridder., Chemical Abstracts, vol. 60, col. 15892, "Derivatives of dialkylxanthines", Jan. 1964.
Singer et al., Bone Marrow Transplantation, 10:19, pp. 19-25, "Effect of Methylxanthine Derivatives on T Cell Activation", 1992.

Affiliated with

Also associated with

Rating

Amine substituted compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amine substituted compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amine substituted compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2007135